Does VEDOLIZUMAB Cause Product distribution issue? 150 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Product distribution issue have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.2% of all adverse event reports for VEDOLIZUMAB.
150
Reports of Product distribution issue with VEDOLIZUMAB
0.2%
of all VEDOLIZUMAB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Product distribution issue From VEDOLIZUMAB?
Of the 150 reports, 3 (2.0%) resulted in death, 20 (13.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
HUMAN C1-ESTERASE INHIBITOR (107)
Which VEDOLIZUMAB Alternatives Have Lower Product distribution issue Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB